NCT04930978View on ClinicalTrials.gov

Effect of SARS-CoV-2 Disease on Immune Responses, Disease Severity and Treatment Outcomes in Pulmonary Tuberculosis

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

June 21, 2021

Primary Completion Date

June 20, 2024

Study Completion Date

June 20, 2024

Conditions
COVID-19 Respiratory InfectionPulmonary Tuberculoses
Trial Locations (1)

600031

RECRUITING

National Institute for Research in Tuberculosis, Chennai

All Listed Sponsors
lead

Tuberculosis Research Centre, India

OTHER_GOV